End-to-end strain characterization, fermentation development, formulation, and mechanism-focused assays—purpose-built to de-risk Streptococcus thermophilus programs for food, nutrition, synbiotic, and live biotherapeutic research. Powered by validated workflows and rigorous QC at Creative Biolabs.
Chosen by leading R&D teams for reproducible, regulatory-conscious microbiome research with S. thermophilus.
S. thermophilus is a high-performance lactic acid bacterium widely used in dairy fermentations, noted for fast lactose utilization, acidification kinetics, and exopolysaccharide (EPS) production that shapes texture and product stability. Its long track record in foods underpins robust safety expectations when properly strain-qualified.
Co-culture behavior with Lactobacillus delbrueckii subsp. bulgaricus and strain-dependent stress tolerance make controlled process development essential. Our platform quantifies carbohydrate use, EPS yield, functional traits, and host-interaction readouts to support rational strain selection, formulation, and scale-up.
Establish batch or fed-batch fermentations for S. thermophilus, optimizing pH control, temperature, carbohydrate feed, and dissolved oxygen to balance acidification rate, viable counts, and EPS output. We parameterize lactose flux, growth kinetics, and post-acidification behavior to deliver a robust, transferable bioprocess suitable for diverse matrices and downstream formulation.
Translate S. thermophilus from shake flasks into 5–20 L reactors with seed-train design, inoculation strategy, and scale-down controls. We deliver frozen or lyophilized pilot lots with full batch records and release testing, enabling realistic stability, co-culture, and application studies ahead of tech transfer to larger assets.
Engineer protective systems for S. thermophilus—carbohydrate carriers, amino acids, and buffered salt blends—to maximize viability through processing, storage, and gastric/bile stress simulations. We match excipient profiles to target use conditions and intended dose forms (powders, capsules, fermented foods), enabling consistent function after rehydration and mixing.
Screen lyophilization and spray-drying parameters for S. thermophilus, control moisture/aw to minimize post-process viability loss, and compare cryo/lyoprotectant combinations for fidelity to starting populations. Build accelerated and real-time stability protocols, model decay kinetics, and establish label-ready shelf-life claims for RUO materials.
Implement standardized QC for S. thermophilus: viable counts, purity and contaminant monitoring, strain ID by 16S/WGS, lactose hydrolysis and acidification kinetics, and EPS quantification. We author fit-for-purpose specifications, in-process controls, and release criteria to lock in batch-to-batch reproducibility and traceability across your program.
Map S. thermophilus utilization of lactose, galactose, and select oligosaccharides, recording acidification curves, endpoints, and metabolic signatures. We resolve strain-level galactose phenotypes, lac operon behavior, and substrate preferences to guide media design, synbiotic pairing, and co-culture ratios with companion starters.
Profile S. thermophilus for EPS generation, bacteriocin-like activity (e.g., thermophilin family), acid/bile tolerance, and stress resilience. For dairy-use cases, we include co-fermentation readouts with L. bulgaricus to capture real-world performance, viscosity contributions, and post-acidification tendencies that impact product quality.
Use in-vitro epithelial models to assess S. thermophilus adhesion, mucin binding, barrier-related metrics (e.g., TEER), and secreted-metabolite impacts. Results contextualize safety/function studies and help prioritize strains for further evaluation in integrated gut-model systems. Optional co-culture designs explore community-level effects with lactobacilli or bifidobacteria.
Align on application scenario, matrices, target specifications, and decision criteria for S. thermophilus selection and process design.
Confirm identity, purity, and key phenotypes; benchmark carbohydrate use, EPS output, and acidification kinetics under reference conditions.
Optimize fermentation parameters for S. thermophilus, codifying control ranges that maximize viability and desired functional attributes.
Select excipients and drying conditions; verify survival in processing and simulated GI stress; set stability protocols.
Screen bacteriocin-like activity, stress tolerance, and host-interaction endpoints; run optional co-culture evaluations.
Produce lab-scale lots with QC release, provide SOPs/specs, and craft a data package for internal governance and tech transfer.
Process, formulation, QC, and MoA data for S. thermophilus harmonized into a single decision framework.
Co-culture and viscosity/EPS analytics tailored to dairy and nutrition scenarios.
Differentiate lactose/galactose phenotypes, stress responses, and bacteriocin potential across candidate strains.
WGS/identity, purity, and stability designs aligned with contemporary food-microbiology expectations for RUO programs.
Seed trains and control strategies that translate from shake flask to 5–20 L and beyond.
Responsive technical team, transparent methods, and clear go/no-go gates to accelerate internal decision-making.
Core starter for yogurt (with L. bulgaricus) and cheeses. Rapid lactose acidification coagulates casein; EPS enhances viscosity, reduces syneresis; proteolysis yields acetaldehyde/diacetyl for clean flavor; thermophilic growth supports robust dairy processing.
Live S. thermophilus supplies β-galactosidase and lowers residual lactose during fermentation and consumption. Evidence shows improved lactose digestion in maldigesters, consistent with EFSA-recognized claims when used in suitable fermented dairy matrices.
Certain S. thermophilus strains produce bacteriocin-like substances (thermophilins) that inhibit indicator or spoilage organisms in vitro, suggesting competitive advantages and potential to influence gut ecological balance in controlled research settings.
Peptides and metabolites from S. thermophilus fermentations and postbiotic preparations show anti-inflammatory signals in experimental models, motivating inclusion in functional prototypes that standardize bioactives under defined processing and stability parameters.
In model systems, S. thermophilus supports short-chain fatty acid formation and balanced microbial communities. These outputs align with barrier and metabolic readouts, warranting mechanism-focused assessment in integrated in-vitro gut platforms.
A genetically tractable S. thermophilus chassis enables targeted enhancement of acidification rates, flavor pathways, and EPS yields, and shows promise for designated molecule expression programs in food biotechnology and RUO biomanufacturing research.
Here is a selection of S. thermophilus related products designed to support your project:
| Product Name | Catalog No. | Target | Product Overview | Size | Price |
|---|---|---|---|---|---|
| Streptococcus thermophilus Powder | LBP-012FG | Streptococcus | Freeze-dried Streptococcus thermophilus powder. | — | |
| Streptococcus thermophilus; PCI1327 | LBST-095FG | Streptococcus | Gram-positive and a fermentative facultative anaerobe; cytochrome/oxidase/catalase negative, alpha-hemolytic positive; non-motile and non–endospore-forming. | — | |
| Streptococcus thermophilus; S01 | LBST-096FG | Streptococcus | Isolated from rhodian starter; Gram-positive, fermentative facultative anaerobe; cytochrome/oxidase/catalase negative, alpha-hemolytic positive; non-motile and non–endospore-forming. | 200 µg | $1,156.00 |
| Streptococcus thermophilus; 20617 | LBGF-0722-GF99 | Streptococcus | Gram-positive, fermentative facultative anaerobe; cytochrome/oxidase/catalase negative, alpha-hemolytic positive; non-motile and non–endospore-forming. | 200 µg | $980.00 |
| Streptococcus thermophilus; 19987 | LBGF-0722-GF100 | Streptococcus | Gram-positive, fermentative facultative anaerobe; cytochrome/oxidase/catalase negative, alpha-hemolytic positive; non-motile and non–endospore-forming. | 200 µg | $1,400.00 |
| Streptococcus thermophilus | LBGF-0722-GF101 | Streptococcus | Gram-positive, fermentative facultative anaerobe; cytochrome/oxidase/catalase negative, alpha-hemolytic positive; non-motile and non–endospore-forming. | 200 µg | $1,590.00 |
| Streptococcus thermophilus DNA Standard | LBGF-0224-GF31 | Streptococcus DNA standard | Streptococcus thermophilus DNA standard for quantitative research and analysis, assay development, verification and validation, and laboratory quality control. | — | |
| Streptococcus thermophilus Genomic DNA | LBGF-0925-GF149 | Streptococcus DNA | High-quality, intact genomic DNA isolated from Streptococcus thermophilus; purified and ready-to-use for PCR, qPCR, and next-generation sequencing. | 5 µg | $720.00 |
S. thermophilus is a thermophilic starter for yogurt and cheeses—often paired with L. bulgaricus—valued for rapid lactose acidification and EPS. It also appears in probiotic research. We deliver analytics, fermentation, formulation, QC, co-culture assays.
We compare lactose, galactose, and select oligosaccharides under controlled pH and temperature, track acidification and biomass curves, and assess lac-operon behavior. The resulting profiles guide media design, synbiotic pairing, and co-culture ratios.
Yes. We run time-resolved kinetics at different inoculum ratios, monitor post-acidification through storage, and quantify viscosity/EPS contributions to product quality, enabling data-driven starter selection for your matrix.
We apply 16S/WGS identification, purity and contaminant panels, viable counts, acidification kinetics, and carbohydrate-use profiling for S. thermophilus. In-process controls, release specifications, and electronic batch records maintain traceability and reproducibility across lab-scale production campaigns.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.